Login
Israel-Hamas Conflict
Military
Social Media
Benjamin Netanyahu
World Cup
Donald Trump
Soccer
Instagram
Wrestling
Stock Markets
Formula 1
Premier League
WWE
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Rheumatology Indication Looks Promising for Efgartigimod

Summary by MedPage Today
(MedPage Today) -- BARCELONA -- A drug targeting immunoglobulin G (IgG) currently approved for myasthenia gravis and chronic inflammatory demyelinating polyneuropathy (CIDP) now looks like it could take the rheumatology field by storm, if phase...

3 Articles

All
Left
Center
1
Right
MedPage TodayMedPage Today
Reposted by
Anti-Aging, Acupuncture and Health NewsAnti-Aging, Acupuncture and Health News
Center

Rheumatology Indication Looks Promising for Efgartigimod

(MedPage Today) -- BARCELONA -- A drug targeting immunoglobulin G (IgG) currently approved for myasthenia gravis and chronic inflammatory demyelinating polyneuropathy (CIDP) now looks like it could take the rheumatology field by storm, if phase...

·New York, United States
Read Full Article
neurologylive.comneurologylive.com

Rationale Behind NVG-2089 as New Therapy for CIDP: Pamela Conley; Alan Glicklich, MD

Members from Nuvig Therapeutics discussed how NVG-2089 could improve the CIDP treatment landscape by offering IVIG-like efficacy with a better safety and administration profile. [WATCH TIME: 3 minutes]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Anti-Aging, Acupuncture and Health News broke the news in on Wednesday, June 11, 2025.
Sources are mostly out of (0)

Similar News Topics

Barcelona

Barcelona

News
For You
SearchBlindspotLocal